Search results
18 kwi 2024 · The response to treatment is measured in 2 ways: (1) improvement or resolution of the clinical presentation of arrhythmias, heart block, or HF and (2) reduction in the degree of active granulomatous inflammation in the myocardium.
16 mar 2023 · Treatment of heart failure. All guideline-directed medical therapies 164 can be used to treat CS-related congestive heart failure. Corticosteroids are indicated if there is proof of active myocardial inflammation.
26 cze 2024 · The multi-disciplinary team based approach to the diagnosis and treatment of cardiac sarcoidosis. CMR, cardiac magnetic resonance; CRT, cardiac resynchronization therapy; ECG, electrocardiogram; FDG-PET, fluorodeoxyglucose positron emission tomography; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ...
Abstract. Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The clinical manifestations of cardiac sarcoidosis (CS) include heart block, atrial arrhythmias, ventricular arrhythmias and heart failure.
25 paź 2019 · JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J. 2019 Oct 25;83 (11):2329-2388. doi: 10.1253/circj.CJ-19-0508. Epub 2019 Oct 9. Authors.
1. Establish working criteria for the diagnosis of cardiac sarcoidosis (CS) on the basis of expert opinion and the limited available data. 2. Provide guidance and recommendations to physicians treating extracardiac sarcoidosis on appropriate screening for possible cardiac involvement. 3. Provide guidance and recommendations to cardiologists
6 lip 2023 · Cardiac sarcoidosis (CS) is a rare multisystem disorder characterized by granulomatous infiltration of the myocardium, which can lead to significant morbidity and mortality. Its...
